Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b double-blind randomized placebo-controlled study of PF-04950615 in hypercholesterolemic subjects on statins
2012-001226-10Phase 2Completed
- Sponsor
- Pfizer
- Start
- May 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bococizumab in hyperlipidemia and hypercholesterolemia (3 arms), sponsored by Pfizer. Primary endpoint: Change in LDL-cholesterol at week 12. Started May 2012; status: completed.
02
Drugs
bococizumab
03
Conditions
hyperlipidemiahypercholesterolemia
Beyond the preview
Go deeper on 2012-001226-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001226-10.